Satsuma Pharmaceuticals, Inc.(STSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

STSA Satsuma Pharmaceuticals, Inc.

退市 07-15 10:39:52 EDT

1.10

+0.00

0.00%

最高1.10	最低1.10	成交量0.00
今开1.10	昨收1.10	日振幅0.00%
总市值3,647万	流通市值1,672万	总股本3,315万
成交额194.10万	换手率0.00%	流通股本1,520万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"STSA","market":"US","secType":"STK","nameCN":"Satsuma Pharmaceuticals, Inc.","latestPrice":1.1,"timestamp":1686168000000,"preClose":1.1,"halted":4,"volume":0,"delay":0,"floatShares":15203712,"shares":33152498,"eps":-1.999338,"marketStatus":"退市","change":0,"latestTime":"07-15 10:39:52 EDT","open":1.1,"high":1.1,"low":1.1,"amount":1940959.8864138997,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.999338,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752609600000},"marketStatusCode":2,"adr":0,"listingDate":1568347200000,"exchange":"NASDAQ","adjPreClose":1.1,"volumeRatio":0},"requestUrl":"/m/hq/s/STSA","defaultTab":"news","newsList":[{"id":"2550465715","title":"舒泰神股价40.50元 公司取得STSA-1002注射液临床研究总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2550465715","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550465715?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:53","pubTimestamp":1752083588,"startTime":"0","endTime":"0","summary":"截至2025年7月9日15时22分，舒泰神股价为40.50元，较前一交易日收盘价下跌0.13元，跌幅为0.32%。当日开盘价为40.00元，最高价为41.66元，最低价为39.25元，成交量为246235.0手，成交额为9.96亿元。舒泰神所属生物制品板块，公司专注于生物制药领域，主要从事创新药物的研发、生产和销售。公司公告显示，舒泰神已取得STSA-1002注射液在急性呼吸窘迫综合征患者中的Ib/II期临床研究总结报告。2025年7月9日，舒泰神主力资金净流出2362.33万元，占流通市值比为0.12%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/10015351595900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4007","BK0046","BK0028","STSA","BK0239","300204"],"gpt_icon":0},{"id":"2549804545","title":"舒泰神：STSA-1002注射液具有良好的安全性和耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=2549804545","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549804545?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:08","pubTimestamp":1751969328,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","BK0239","STSA","BK0046","300204","BK0028"],"gpt_icon":0},{"id":"2539286146","title":"【创新药概念再度走强 舒泰神涨超15%创3年新高】早盘舒泰神涨超15%，股价创3年多新高，键凯科技、博瑞医药、健友股份、三生国健、益方生物等涨幅靠前。消息面上，舒泰神公告，STSA-1002注射液在急性呼吸窘迫综合征（ARDS）适应症下获得了Ib/II期临床试验研究的初步结果。28天全因死亡率数据显示，低剂量组和高剂量组分别为26.67%和5.88%，较对照组的40%分别降低了33.33%和85.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539286146","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539286146?lang=zh_cn&edition=full","pubTime":"2025-05-29 09:42","pubTimestamp":1748482932,"startTime":"0","endTime":"0","summary":"早盘舒泰神涨超15%，股价创3年多新高，键凯科技、博瑞医药、健友股份、三生国健、益方生物等涨幅靠前。消息面上，舒泰神公告，STSA-1002注射液在急性呼吸窘迫综合征（ARDS）适应症下获得了Ib/II期临床试验研究的初步结果。28天全因死亡率数据显示，低剂量组和高剂量组分别为26.67%和5.88%，较对照组的40%分别降低了33.33%和85.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/29094250733134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1576","BK0186","ARDS","688356","BK1574","BK1583","BK4007","BK0046","BK4139","688166","BK0239","603707","300204","BK1161","BK0028","688382","BK1141","06978","688336","BK0229","03347","159992","STSA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.satsumarx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Satsuma Pharmaceuticals, Inc.于2016年6月21日在特拉华州注册成立，是一家临床阶段的生物制药公司，开发一种治疗偏头痛急性治疗的新型治疗药物。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.18106},{"month":2,"riseRate":0.5,"avgChangeRate":-0.018348},{"month":3,"riseRate":0.25,"avgChangeRate":-0.137},{"month":4,"riseRate":0.5,"avgChangeRate":0.08762},{"month":5,"riseRate":0.25,"avgChangeRate":0.034529},{"month":6,"riseRate":1,"avgChangeRate":0.195405},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.113868},{"month":8,"riseRate":0.333333,"avgChangeRate":0.112636},{"month":9,"riseRate":0,"avgChangeRate":-0.31806},{"month":10,"riseRate":0.25,"avgChangeRate":-0.048014},{"month":11,"riseRate":0.5,"avgChangeRate":-0.101074},{"month":12,"riseRate":0.5,"avgChangeRate":0.052715}],"exchange":"NASDAQ","name":"Satsuma Pharmaceuticals, Inc.","nameEN":"Satsuma Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Satsuma Pharmaceuticals, Inc.(STSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Satsuma Pharmaceuticals, Inc.(STSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Satsuma Pharmaceuticals, Inc.,STSA,Satsuma Pharmaceuticals, Inc.股票,Satsuma Pharmaceuticals, Inc.股票老虎,Satsuma Pharmaceuticals, Inc.股票老虎国际,Satsuma Pharmaceuticals, Inc.行情,Satsuma Pharmaceuticals, Inc.股票行情,Satsuma Pharmaceuticals, Inc.股价,Satsuma Pharmaceuticals, Inc.股市,Satsuma Pharmaceuticals, Inc.股票价格,Satsuma Pharmaceuticals, Inc.股票交易,Satsuma Pharmaceuticals, Inc.股票购买,Satsuma Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Satsuma Pharmaceuticals, Inc.(STSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Satsuma Pharmaceuticals, Inc.(STSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}